nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—Hypotensive—Teniposide—lymphatic system cancer	0.0617	0.0655	CcSEcCtD
Tetrabenazine—CBR1—Azacitidine—Fludarabine—lymphatic system cancer	0.0299	0.514	CbGdCrCtD
Tetrabenazine—CBR1—Azacitidine—Cytarabine—lymphatic system cancer	0.0282	0.486	CbGdCrCtD
Tetrabenazine—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.0244	0.0259	CcSEcCtD
Tetrabenazine—Depression—Mechlorethamine—lymphatic system cancer	0.017	0.0181	CcSEcCtD
Tetrabenazine—Sleep disorder—Fludarabine—lymphatic system cancer	0.0166	0.0176	CcSEcCtD
Tetrabenazine—Gait disturbance—Carmustine—lymphatic system cancer	0.013	0.0138	CcSEcCtD
Tetrabenazine—Dysphagia—Fludarabine—lymphatic system cancer	0.0124	0.0132	CcSEcCtD
Tetrabenazine—Gait disturbance—Vincristine—lymphatic system cancer	0.0124	0.0132	CcSEcCtD
Tetrabenazine—Sweating—Teniposide—lymphatic system cancer	0.0121	0.0128	CcSEcCtD
Tetrabenazine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.012	0.0127	CcSEcCtD
Tetrabenazine—Bronchitis—Fludarabine—lymphatic system cancer	0.0119	0.0127	CcSEcCtD
Tetrabenazine—Disorientation—Bleomycin—lymphatic system cancer	0.0118	0.0125	CcSEcCtD
Tetrabenazine—Dysuria—Fludarabine—lymphatic system cancer	0.0116	0.0123	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.0115	0.0123	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0113	0.012	CcSEcCtD
Tetrabenazine—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.0106	0.0113	CcSEcCtD
Tetrabenazine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0106	0.0112	CcSEcCtD
Tetrabenazine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00948	0.0101	CcSEcCtD
Tetrabenazine—Agitation—Teniposide—lymphatic system cancer	0.00905	0.00961	CcSEcCtD
Tetrabenazine—Leukopenia—Teniposide—lymphatic system cancer	0.00881	0.00936	CcSEcCtD
Tetrabenazine—Ataxia—Carmustine—lymphatic system cancer	0.00865	0.00918	CcSEcCtD
Tetrabenazine—Ataxia—Vincristine—lymphatic system cancer	0.00825	0.00876	CcSEcCtD
Tetrabenazine—Confusional state—Teniposide—lymphatic system cancer	0.0081	0.0086	CcSEcCtD
Tetrabenazine—Agitation—Fludarabine—lymphatic system cancer	0.00795	0.00844	CcSEcCtD
Tetrabenazine—Dysphagia—Carmustine—lymphatic system cancer	0.00795	0.00844	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00781	0.00829	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00777	0.00825	CcSEcCtD
Tetrabenazine—Leukopenia—Fludarabine—lymphatic system cancer	0.00775	0.00822	CcSEcCtD
Tetrabenazine—Hypotension—Teniposide—lymphatic system cancer	0.00751	0.00797	CcSEcCtD
Tetrabenazine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00746	0.00792	CcSEcCtD
Tetrabenazine—Dyspnoea—Teniposide—lymphatic system cancer	0.00716	0.00761	CcSEcCtD
Tetrabenazine—Confusional state—Fludarabine—lymphatic system cancer	0.00712	0.00756	CcSEcCtD
Tetrabenazine—Dysuria—Vincristine—lymphatic system cancer	0.0071	0.00753	CcSEcCtD
Tetrabenazine—Depression—Carmustine—lymphatic system cancer	0.00707	0.0075	CcSEcCtD
Tetrabenazine—Decreased appetite—Teniposide—lymphatic system cancer	0.00699	0.00742	CcSEcCtD
Tetrabenazine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00693	0.00736	CcSEcCtD
Tetrabenazine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00693	0.00735	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00687	0.00729	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00683	0.00725	CcSEcCtD
Tetrabenazine—Depression—Vincristine—lymphatic system cancer	0.00675	0.00716	CcSEcCtD
Tetrabenazine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00662	0.00703	CcSEcCtD
Tetrabenazine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00659	0.00699	CcSEcCtD
Tetrabenazine—Sweating—Vincristine—lymphatic system cancer	0.00649	0.00689	CcSEcCtD
Tetrabenazine—Nausea—Mechlorethamine—lymphatic system cancer	0.00647	0.00687	CcSEcCtD
Tetrabenazine—Body temperature increased—Teniposide—lymphatic system cancer	0.00635	0.00674	CcSEcCtD
Tetrabenazine—Sweating—Mitoxantrone—lymphatic system cancer	0.00632	0.00671	CcSEcCtD
Tetrabenazine—Dyspnoea—Fludarabine—lymphatic system cancer	0.0063	0.00668	CcSEcCtD
Tetrabenazine—Dysarthria—Methotrexate—lymphatic system cancer	0.0062	0.00659	CcSEcCtD
Tetrabenazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00614	0.00652	CcSEcCtD
Tetrabenazine—Fatigue—Fludarabine—lymphatic system cancer	0.00609	0.00646	CcSEcCtD
Tetrabenazine—Constipation—Fludarabine—lymphatic system cancer	0.00604	0.00641	CcSEcCtD
Tetrabenazine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00602	0.00639	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.006	0.00637	CcSEcCtD
Tetrabenazine—Urethral disorder—Vincristine—lymphatic system cancer	0.00595	0.00632	CcSEcCtD
Tetrabenazine—Eye disorder—Carmustine—lymphatic system cancer	0.00595	0.00631	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00582	0.00618	CcSEcCtD
Tetrabenazine—Asthenia—Teniposide—lymphatic system cancer	0.00577	0.00612	CcSEcCtD
Tetrabenazine—Leukopenia—Bleomycin—lymphatic system cancer	0.00568	0.00603	CcSEcCtD
Tetrabenazine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00564	0.00598	CcSEcCtD
Tetrabenazine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00558	0.00593	CcSEcCtD
Tetrabenazine—Mental disorder—Carmustine—lymphatic system cancer	0.00557	0.00592	CcSEcCtD
Tetrabenazine—Angiopathy—Vincristine—lymphatic system cancer	0.00551	0.00585	CcSEcCtD
Tetrabenazine—Diarrhoea—Teniposide—lymphatic system cancer	0.0055	0.00584	CcSEcCtD
Tetrabenazine—Mental disorder—Vincristine—lymphatic system cancer	0.00532	0.00565	CcSEcCtD
Tetrabenazine—Ecchymosis—Methotrexate—lymphatic system cancer	0.00531	0.00563	CcSEcCtD
Tetrabenazine—Confusional state—Bleomycin—lymphatic system cancer	0.00522	0.00554	CcSEcCtD
Tetrabenazine—Tremor—Carmustine—lymphatic system cancer	0.00519	0.00551	CcSEcCtD
Tetrabenazine—Vomiting—Teniposide—lymphatic system cancer	0.00511	0.00542	CcSEcCtD
Tetrabenazine—Agitation—Carmustine—lymphatic system cancer	0.00509	0.0054	CcSEcCtD
Tetrabenazine—Asthenia—Fludarabine—lymphatic system cancer	0.00507	0.00538	CcSEcCtD
Tetrabenazine—Headache—Teniposide—lymphatic system cancer	0.00503	0.00534	CcSEcCtD
Tetrabenazine—Leukopenia—Carmustine—lymphatic system cancer	0.00496	0.00526	CcSEcCtD
Tetrabenazine—Agitation—Vincristine—lymphatic system cancer	0.00486	0.00516	CcSEcCtD
Tetrabenazine—Hypotension—Bleomycin—lymphatic system cancer	0.00484	0.00514	CcSEcCtD
Tetrabenazine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00483	0.00513	CcSEcCtD
Tetrabenazine—Nausea—Teniposide—lymphatic system cancer	0.00477	0.00507	CcSEcCtD
Tetrabenazine—Leukopenia—Vincristine—lymphatic system cancer	0.00473	0.00502	CcSEcCtD
Tetrabenazine—Anxiety—Carmustine—lymphatic system cancer	0.0047	0.00499	CcSEcCtD
Tetrabenazine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00462	0.0049	CcSEcCtD
Tetrabenazine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00461	0.00489	CcSEcCtD
Tetrabenazine—Confusional state—Carmustine—lymphatic system cancer	0.00456	0.00484	CcSEcCtD
Tetrabenazine—Decreased appetite—Bleomycin—lymphatic system cancer	0.0045	0.00478	CcSEcCtD
Tetrabenazine—Vomiting—Fludarabine—lymphatic system cancer	0.00449	0.00477	CcSEcCtD
Tetrabenazine—Headache—Fludarabine—lymphatic system cancer	0.00442	0.0047	CcSEcCtD
Tetrabenazine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00437	0.00464	CcSEcCtD
Tetrabenazine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00427	0.00453	CcSEcCtD
Tetrabenazine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00426	0.00452	CcSEcCtD
Tetrabenazine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00424	0.0045	CcSEcCtD
Tetrabenazine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00423	0.00449	CcSEcCtD
Tetrabenazine—Hypotension—Carmustine—lymphatic system cancer	0.00422	0.00448	CcSEcCtD
Tetrabenazine—Nausea—Fludarabine—lymphatic system cancer	0.00419	0.00445	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00417	0.00443	CcSEcCtD
Tetrabenazine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00409	0.00435	CcSEcCtD
Tetrabenazine—Insomnia—Carmustine—lymphatic system cancer	0.00409	0.00434	CcSEcCtD
Tetrabenazine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00408	0.00433	CcSEcCtD
Tetrabenazine—Irritability—Methotrexate—lymphatic system cancer	0.00407	0.00432	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00406	0.00431	CcSEcCtD
Tetrabenazine—Hypotension—Vincristine—lymphatic system cancer	0.00403	0.00428	CcSEcCtD
Tetrabenazine—Dyspnoea—Carmustine—lymphatic system cancer	0.00403	0.00428	CcSEcCtD
Tetrabenazine—Somnolence—Carmustine—lymphatic system cancer	0.00402	0.00427	CcSEcCtD
Tetrabenazine—Ataxia—Methotrexate—lymphatic system cancer	0.00401	0.00425	CcSEcCtD
Tetrabenazine—Decreased appetite—Carmustine—lymphatic system cancer	0.00393	0.00417	CcSEcCtD
Tetrabenazine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00393	0.00417	CcSEcCtD
Tetrabenazine—Insomnia—Vincristine—lymphatic system cancer	0.0039	0.00414	CcSEcCtD
Tetrabenazine—Constipation—Carmustine—lymphatic system cancer	0.00387	0.0041	CcSEcCtD
Tetrabenazine—Breast disorder—Methotrexate—lymphatic system cancer	0.00385	0.00409	CcSEcCtD
Tetrabenazine—Decreased appetite—Vincristine—lymphatic system cancer	0.00375	0.00398	CcSEcCtD
Tetrabenazine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00375	0.00398	CcSEcCtD
Tetrabenazine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00374	0.00397	CcSEcCtD
Tetrabenazine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00372	0.00395	CcSEcCtD
Tetrabenazine—Fatigue—Vincristine—lymphatic system cancer	0.00372	0.00395	CcSEcCtD
Tetrabenazine—Asthenia—Bleomycin—lymphatic system cancer	0.00372	0.00394	CcSEcCtD
Tetrabenazine—Constipation—Vincristine—lymphatic system cancer	0.00369	0.00392	CcSEcCtD
Tetrabenazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00365	0.00388	CcSEcCtD
Tetrabenazine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00362	0.00385	CcSEcCtD
Tetrabenazine—Constipation—Mitoxantrone—lymphatic system cancer	0.00359	0.00381	CcSEcCtD
Tetrabenazine—Body temperature increased—Carmustine—lymphatic system cancer	0.00357	0.00379	CcSEcCtD
Tetrabenazine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00346	0.00368	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—lymphatic system cancer	0.00344	0.00365	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00342	0.00363	CcSEcCtD
Tetrabenazine—Body temperature increased—Vincristine—lymphatic system cancer	0.00341	0.00362	CcSEcCtD
Tetrabenazine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00332	0.00353	CcSEcCtD
Tetrabenazine—Vomiting—Bleomycin—lymphatic system cancer	0.00329	0.0035	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—lymphatic system cancer	0.00328	0.00348	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—lymphatic system cancer	0.00327	0.00347	CcSEcCtD
Tetrabenazine—Asthenia—Carmustine—lymphatic system cancer	0.00324	0.00344	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—lymphatic system cancer	0.00315	0.00334	CcSEcCtD
Tetrabenazine—Asthenia—Vincristine—lymphatic system cancer	0.0031	0.00329	CcSEcCtD
Tetrabenazine—Diarrhoea—Carmustine—lymphatic system cancer	0.00309	0.00328	CcSEcCtD
Tetrabenazine—Nausea—Bleomycin—lymphatic system cancer	0.00308	0.00327	CcSEcCtD
Tetrabenazine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00301	0.0032	CcSEcCtD
Tetrabenazine—Dizziness—Carmustine—lymphatic system cancer	0.00299	0.00317	CcSEcCtD
Tetrabenazine—Diarrhoea—Vincristine—lymphatic system cancer	0.00295	0.00313	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00291	0.00309	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—lymphatic system cancer	0.00289	0.00307	CcSEcCtD
Tetrabenazine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00288	0.00305	CcSEcCtD
Tetrabenazine—Vomiting—Carmustine—lymphatic system cancer	0.00287	0.00305	CcSEcCtD
Tetrabenazine—Dizziness—Vincristine—lymphatic system cancer	0.00285	0.00303	CcSEcCtD
Tetrabenazine—Headache—Carmustine—lymphatic system cancer	0.00283	0.00301	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—lymphatic system cancer	0.00275	0.00292	CcSEcCtD
Tetrabenazine—Vomiting—Vincristine—lymphatic system cancer	0.00274	0.00291	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00273	0.0029	CcSEcCtD
Tetrabenazine—Headache—Vincristine—lymphatic system cancer	0.0027	0.00287	CcSEcCtD
Tetrabenazine—Nausea—Carmustine—lymphatic system cancer	0.00268	0.00285	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—lymphatic system cancer	0.00267	0.00284	CcSEcCtD
Tetrabenazine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00267	0.00284	CcSEcCtD
Tetrabenazine—Headache—Mitoxantrone—lymphatic system cancer	0.00263	0.00279	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—lymphatic system cancer	0.00258	0.00274	CcSEcCtD
Tetrabenazine—Nausea—Vincristine—lymphatic system cancer	0.00256	0.00272	CcSEcCtD
Tetrabenazine—Nausea—Mitoxantrone—lymphatic system cancer	0.0025	0.00265	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—lymphatic system cancer	0.0023	0.00244	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00217	0.0023	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—lymphatic system cancer	0.00211	0.00224	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00205	0.00218	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—lymphatic system cancer	0.00203	0.00216	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00202	0.00215	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—lymphatic system cancer	0.00196	0.00208	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—lymphatic system cancer	0.00189	0.00201	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00187	0.00198	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—lymphatic system cancer	0.00186	0.00198	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00182	0.00193	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—lymphatic system cancer	0.00181	0.00192	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00173	0.00183	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00166	0.00176	CcSEcCtD
Tetrabenazine—Asthenia—Methotrexate—lymphatic system cancer	0.0015	0.00159	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00143	0.00152	CcSEcCtD
Tetrabenazine—Dizziness—Methotrexate—lymphatic system cancer	0.00138	0.00147	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—lymphatic system cancer	0.00133	0.00141	CcSEcCtD
Tetrabenazine—Headache—Methotrexate—lymphatic system cancer	0.00131	0.00139	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—lymphatic system cancer	0.00124	0.00132	CcSEcCtD
